ERAS+ – enhanced recovery for major cancer surgery

Summary

Greater Manchester Medical Health aims to improve 5-year survival to 70% for all cancers, and has developed a new enhanced recovery surgery pathway aimed specifically at major cancer surgery patients. Developed by the ERAS+ team, it has been used over the last 12 months in more than 500 cancer patients and has demonstrated a substantial reduction in post-operative pulmonary complications in the major cancer surgical population in an acute NHS setting. This has major implications for cancer surgery and potentially 5-year survival. The team believes its toolset of innovations could be rapidly dispersed across the NHS.

Challenge

The World Health Organization has set the target of improving cancer survival by 25% by 2025. Greater Manchester Medical Health aims to improve 5-year survival to 70% for all cancer patients – and an important determinant of major cancer survival is the development of post-operative complications.

Objectives

To equip patients and their families with the tools to optimise patient preparation and recovery for surgery. To explain to patients how they can best prepare for their operation and how we plan to reduce their risk of pulmonary complications. To deliver a more patient- and family-focused pathway.

Back to the top



Contacts

Dr John Moore

Job title:
Clinical Director in Adult Critical Care, Consultant in Anaesthetic and Critical Care
Place of work:
Manchester Royal Infirmary
Telephone:
0161 901 6017
Email:
john.moore@cmft.nhs.uk


QiC Oncology 2016 partner:
Bristol-Myers Squibb
Supported by: